Application of T cell-based transcriptomics to identify three candidate biomarkers for monitoring anti-TGFbetaR therapy.
Classen S, Muth C, Debey-Pascher S, Eggle D, Beyer M, Mallmann MR, Rudlowski C, Zander T, Pölcher M, Kuhn W, Lahn M, Schultze JL, Staratschek-Jox A.
Classen S, et al. Among authors: zander t.
Pharmacogenet Genomics. 2010 Mar;20(3):147-56. doi: 10.1097/FPC.0b013e328335731c.
Pharmacogenet Genomics. 2010.
PMID: 20084050